Medicare Enrolled
Dr. Eliezer Castaneda, M.D.
Family Medicine · Victoria, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Castaneda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Castaneda?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Castaneda
Dr. Eliezer Castaneda is a family medicine specialist in Victoria, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Castaneda performed 3,035 Medicare services across 1,138 unique beneficiaries.
Between the years covered by Open Payments, Dr. Castaneda received a total of $11,574 from 57 pharmaceutical and/or device companies across 867 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Castaneda is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 8% volume in TX
$11,574 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,035
Medicare services
Top 8% in TX for family medicine
1,138
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~253 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
954 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
584 | $81 | $140 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
227 | $9 | $29 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
215 | $0 | $22 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
165 | $0 | $29 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
161 | $56 | $89 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
136 | $0 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
118 | $88 | $102 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
86 | $36 | $123 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
69 | $48 | $98 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
61 | $85 | $140 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
46 | $82 | $240 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
41 | $48 | $118 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
34 | $147 | $199 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $62 | $194 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
26 | $59 | $100 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
23 | $3 | $17 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $123 | $187 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
14 | $159 | $188 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $132 | $340 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
11 | $160 | $220 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,574
Total received (2018-2024)
Avg $1,653/year across 7 years
Top 4% in TX for family medicine
57
Companies
867
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,525 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$49 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,039
2023
$1,923
2022
$1,860
2021
$2,052
2020
$1,485
2019
$1,153
2018
$1,062
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,881
AstraZeneca Pharmaceuticals LP
$1,250
Boehringer Ingelheim Pharmaceuticals, Inc.
$824
AbbVie Inc.
$744
GlaxoSmithKline, LLC.
$735
Lilly USA, LLC
$734
ABBVIE INC.
$588
PFIZER INC.
$498
Amgen Inc.
$395
Novartis Pharmaceuticals Corporation
$364
Bayer HealthCare Pharmaceuticals Inc.
$206
Biohaven Pharmaceutical Holding Company Ltd.
$200
Astellas Pharma US Inc
$195
Takeda Pharmaceuticals U.S.A., Inc.
$190
Allergan, Inc.
$174
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$163
Eisai Inc.
$158
Merck Sharp & Dohme LLC
$145
SANOFI-AVENTIS U.S. LLC
$133
Horizon Therapeutics plc
$119
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$118
Kowa Pharmaceuticals America, Inc.
$111
Baxter Healthcare
$104
Merck Sharp & Dohme Corporation
$104
E.R. Squibb & Sons, L.L.C.
$102
Antares Pharma, Inc.
$101
Relypsa, Inc.
$94
Amarin Pharma Inc.
$80
Janssen Pharmaceuticals, Inc
$77
Biohaven Pharmaceuticals, Inc.
$72
ARBOR PHARMACEUTICALS, INC.
$71
Shire North American Group Inc
$64
Allergan Inc.
$61
Bayer Healthcare Pharmaceuticals Inc.
$60
IDORSIA PHARMACEUTICALS US INC
$53
ITI, Inc.
$45
Esperion Therapeutics, Inc.
$45
Advanced Respiratory, Inc
$41
Otsuka America Pharmaceutical, Inc.
$40
Inspire Medical Systems, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$39
Axsome Therapeutics, Inc.
$34
Exact Sciences Corporation
$32
Dexcom, Inc.
$32
Supernus Pharmaceuticals, Inc.
$31
Sumitomo Pharma America, Inc.
$28
Almatica Pharma LLC
$23
Phathom Pharmaceuticals, Inc.
$21
Radius Health, Inc.
$21
Optinose US, Inc.
$20
Harmony Biosciences LLC
$20
HARMONY BIOSCIENCES LLC
$19
Sanofi Pasteur Inc.
$19
Corium, LLC
$15
DePuy Synthes Sales Inc.
$14
Synergy Pharmaceuticals Inc
$13
RedHill Biopharma Inc.
$12
Top 3 companies account for 34.2% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AREXVY · Aemcolo · Aimovig · Amitiza · Auvelity · Azstarys · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CAPLYTA · CAPVAXIVE · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DIABETES - DISEASE · DUEXIS · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVUSHELD · Edarbi · Edarbyclor · FARXIGA · GARDASIL 9 · GEMTESA · GRALISE · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Horizant · INSPIRE · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · Life 2000 Ventilation System · Livalo · MENACTRA · MONOVISC · MOUNJARO · MYDAYIS · MYRBETRIQ · NEXLETOL · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SUNOSI · SYMBICORT · Saxenda · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · The Vest System Model 105 Home Care · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veltassa · Veozah · Victoza · WAKIX · Wakix · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xhance
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in TX.
Equivalent to $381 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
71
Per 100K population
77.8
County median income
$70,101
Nearest hospital
CITIZENS MEDICAL CENTER
7.9 mi
7.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Castaneda is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), with low-engagement industry engagement in the top 4% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Castaneda experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Castaneda performed 954 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Castaneda receive payments from pharmaceutical companies?
Yes. Dr. Castaneda received a total of $11,574 from 57 companies across 867 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Castaneda's costs compare to other family medicine physicians in Victoria?
Dr. Castaneda's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Castaneda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Victoria
Browse family medicine physicians in Victoria ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology